Marleen Ansems

1.1k total citations
38 papers, 835 citations indexed

About

Marleen Ansems is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Marleen Ansems has authored 38 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 16 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Marleen Ansems's work include Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (7 papers). Marleen Ansems is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (7 papers). Marleen Ansems collaborates with scholars based in Netherlands, United States and Australia. Marleen Ansems's co-authors include Gosse J. Adema, Paul N. Span, Maaike W.G. Looman, Annemiek B. van Spriel, Saartje Hontelez, Johan Bussink, Friederike Meyer‐Wentrup, Mark D. Wright, Peter Brossart and Carl G. Figdor and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Marleen Ansems

37 papers receiving 828 citations

Peers

Countries citing papers authored by Marleen Ansems

Since Specialization

Citations

This map shows the geographic impact of Marleen Ansems's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marleen Ansems with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marleen Ansems more than expected).

Fields of papers citing papers by Marleen Ansems

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marleen Ansems. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marleen Ansems. The network helps show where Marleen Ansems may publish in the future.

Co-authorship network of co-authors of Marleen Ansems

This figure shows the co-authorship network connecting the top 25 collaborators of Marleen Ansems. A scholar is included among the top collaborators of Marleen Ansems based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marleen Ansems. Marleen Ansems is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cells and macrophages 2025 ·npj Vaccines ·(unknown), Lenneke A. M. Cornelissen, (unknown), Marleen Ansems, Nataschja I. Ho, Gosse J. Adema	6
2	ATM and ATR inhibition increases radiosensitivity and cGAS-STING activation in prostate cancer 2025 ·Cytokine ·(unknown), (unknown), Maaike W.G. Looman, (unknown), Esther D. Kers‐Rebel, Wenny J.M. Peeters, (unknown), (unknown), Robert Jan Smeenk, Marcel Verheij, Marleen Ansems, Gosse J. Adema	1
3	Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment 2024 ·Journal of Experimental & Clinical Cancer Research ·(unknown), Gosse J. Adema, Johan Bussink, Marleen Ansems	21
4	RNA-based logic for selective protein expression in senescent cells 2024 ·The International Journal of Biochemistry & Cell Biology ·(unknown), Masoomeh Khalifeh, M. Koot, (unknown), (unknown), Marleen Ansems, Wouter P. R. Verdurmen, Roland Brock	1
5	MHC-I and PD-L1 Expression is Associated with Decreased Tumor Outgrowth and is Radiotherapy-inducible in the Murine Head and Neck Squamous Cell Carcinoma Model MOC1 2024 ·Molecular Imaging and Biology ·(unknown), (unknown), Marleen Ansems, Renske J.E. van den Bijgaart, Johannes Peters, Paul N. Span, Gosse J. Adema, Sandra Heskamp, Johan Bussink	3
6	NSAIDs affect dendritic cell cytokine production 2022 ·PLoS ONE ·Tonke K. Raaijmakers, Renske J.E. van den Bijgaart, Gert Jan Scheffer, Marleen Ansems, Gosse J. Adema	4
7	cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity 2022 ·Radiotherapy and Oncology ·(unknown), (unknown), Marleen Ansems, Gosse J. Adema	27
8	Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines 2021 ·Cancers ·(unknown), Marleen Ansems, William P. J. Leenders, Johan Bussink, Paul N. Span	11
9	MR-Guided Radiotherapy: The Perfect Partner for Immunotherapy? 2021 ·Frontiers in Oncology ·Juliane Hörner‐Rieber, Sebastian Klüter, Jürgen Debus, Gosse J. Adema, Marleen Ansems, Marcel Verheij	8
10	AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC 2020 ·Radiotherapy and Oncology ·(unknown), Johan Bussink, Marleen Ansems, Ester M. Hammond, Paul N. Span	7
11	ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker 2019 ·Cancers ·(unknown), (unknown), Monique C. de Jong, Johannes H.A.M. Kaanders, William P. J. Leenders, Marleen Ansems, Johan Bussink, Paul N. Span	22
12	Modular actin nano-architecture enables podosome protrusion and mechanosensing 2019 ·Nature Communications ·Koen van den Dries, Leila Nahidiazar, Johan A. Slotman, Marjolein B.M. Meddens, Elvis Pandžić, Ben Joosten, Marleen Ansems, (unknown), (unknown), R Steen, Mietske Wijers, Jack Fransen, Adriaan B. Houtsmuller, Paul W. Wiseman, Kees Jalink, Alessandra Cambi	53
13	Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell Function 2018 ·Frontiers in Immunology ·(unknown), Esther D. Kers‐Rebel, Maaike W.G. Looman, Hiroshi Ichinose, Carlie J.M. de Vries, Marleen Ansems	21
14	DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells 2015 ·Breast Cancer Research and Treatment ·Marleen Ansems, Jonas Nørskov Søndergaard, Anieta M. Sieuwerts, Maaike W.G. Looman, Marcel Smid, Annemarie M.A. de Graaf, Vanja de Weerd, Malou Zuidscherwoude, John A. Foekens, John W.M. Martens, Gosse J. Adema	10
15	Nuclear receptor expression patterns in murine plasmacytoid and conventional dendritic cells 2013 ·Molecular Immunology ·(unknown), Saartje Hontelez, Maaike W.G. Looman, Annemiek B. van Spriel, Marleen Ansems, Gosse J. Adema	6
16	DC‐SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cells 2012 ·The Prostate ·Marleen Ansems, (unknown), Saartje Hontelez, Tilly Aalders, Maaike W.G. Looman, Gerald W. Verhaegh, Jack A. Schalken, Gosse J. Adema	10
17	Crosstalk and DC-SCRIPT: Expanding nuclear receptor modulation 2010 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Marleen Ansems, Saartje Hontelez, (unknown), Paul N. Span, Gosse J. Adema	10
18	DC-SCRIPT: Nuclear Receptor Modulation and Prognostic Significance in Primary Breast Cancer 2009 ·JNCI Journal of the National Cancer Institute ·Marleen Ansems, Saartje Hontelez, Maaike W.G. Looman, (unknown), Peter Bult, Han J. Bonenkamp, (unknown), Fred C.G.J. Sweep, Paul N. Span, Gosse J. Adema	15
19	Dectin-1 Interaction with Tetraspanin CD37 Inhibits IL-6 Production 2007 ·The Journal of Immunology ·Friederike Meyer‐Wentrup, Carl G. Figdor, Marleen Ansems, Peter Brossart, Mark D. Wright, Gosse J. Adema, Annemiek B. van Spriel	79
20	REPAT, a new family of proteins induced by bacterial toxins and baculovirus infection in Spodoptera exigua 2007 ·Insect Biochemistry and Molecular Biology ·Salvador Herrero, Marleen Ansems, Monique M. van Oers, Just M. Vlak, Petra L. Bakker, Ruud A. de Maagd	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact